Cargando…

GNE myopathy: History, etiology, and treatment trials

GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Mullen, Jeffrey, Alrasheed, Khalid, Mozaffar, Tahseen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623016/
https://www.ncbi.nlm.nih.gov/pubmed/36330422
http://dx.doi.org/10.3389/fneur.2022.1002310
_version_ 1784821898603921408
author Mullen, Jeffrey
Alrasheed, Khalid
Mozaffar, Tahseen
author_facet Mullen, Jeffrey
Alrasheed, Khalid
Mozaffar, Tahseen
author_sort Mullen, Jeffrey
collection PubMed
description GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy shows atrophic fibers and rimmed vacuoles without inflammation. Inherited in an autosomal recessive manner, patients with GNE myopathy carry mutations in the GNE gene which affect the sialic acid synthesis pathway. Here, we look at the history and clinical aspects of GNE myopathy, as well as focus on prior treatment trials and challenges and unmet needs related to this disorder.
format Online
Article
Text
id pubmed-9623016
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96230162022-11-02 GNE myopathy: History, etiology, and treatment trials Mullen, Jeffrey Alrasheed, Khalid Mozaffar, Tahseen Front Neurol Neurology GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy shows atrophic fibers and rimmed vacuoles without inflammation. Inherited in an autosomal recessive manner, patients with GNE myopathy carry mutations in the GNE gene which affect the sialic acid synthesis pathway. Here, we look at the history and clinical aspects of GNE myopathy, as well as focus on prior treatment trials and challenges and unmet needs related to this disorder. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9623016/ /pubmed/36330422 http://dx.doi.org/10.3389/fneur.2022.1002310 Text en Copyright © 2022 Mullen, Alrasheed and Mozaffar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Mullen, Jeffrey
Alrasheed, Khalid
Mozaffar, Tahseen
GNE myopathy: History, etiology, and treatment trials
title GNE myopathy: History, etiology, and treatment trials
title_full GNE myopathy: History, etiology, and treatment trials
title_fullStr GNE myopathy: History, etiology, and treatment trials
title_full_unstemmed GNE myopathy: History, etiology, and treatment trials
title_short GNE myopathy: History, etiology, and treatment trials
title_sort gne myopathy: history, etiology, and treatment trials
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623016/
https://www.ncbi.nlm.nih.gov/pubmed/36330422
http://dx.doi.org/10.3389/fneur.2022.1002310
work_keys_str_mv AT mullenjeffrey gnemyopathyhistoryetiologyandtreatmenttrials
AT alrasheedkhalid gnemyopathyhistoryetiologyandtreatmenttrials
AT mozaffartahseen gnemyopathyhistoryetiologyandtreatmenttrials